CompoAtlas

TASLY MYASTRA PILLS

TASLY MYASTRA PILLS : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Dalbergia odoriferaDalbergia odorifera[5.71 mg,520 mg]Not identified
Panax notoginsengPanax notoginseng[85.71 mg,520 mg]Not identified
Salvia miltiorrhizaSalvia miltiorrhiza[428.57 mg,520 mg]Not identified
Astragalus membranaceusAstragalus membranaceus[857.14 mg,520 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL20066133T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
TASLY (MALAYSIA) SDN. BHD.
Manufacturer
TASLY PHARMACEUTICAL GROUP CO., LTD.
Importer
TASLY (MALAYSIA) SDN. BHD.
Registration period starting
2025-06-24
Published validity end
2030-06-24

Original register data

View published fields and their variants
Active ingredients
Dalbergia odorifera[5.71 mg,520 mg],Panax notoginseng[85.71 mg,520 mg],Salvia miltiorrhiza[428.57 mg,520 mg],Astragalus membranaceus[857.14 mg,520 mg]
Valid until
2030-06-24
Registration date
2025-06-24
Published description
NATURAL PRODUCT
Licence holder
TASLY (MALAYSIA) SDN. BHD.
Importer
TASLY (MALAYSIA) SDN. BHD.
Producer
TASLY PHARMACEUTICAL GROUP CO., LTD.
Published name
TASLY MYASTRA PILLS
Published reference
201911273032T
Registration number
MAL20066133T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL20066133T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Astragalus membranaceus
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    Sources cited by Health Canada (2)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.

    Health Canada monograph dated 30 May 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “TASLY MYASTRA PILLS”, https://compoatlas.com/en/supplements/malaysia/MAL20066133T-tasly-myastra-pills, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line